Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Angiotensin II Type-1 Receptor Protein

AGTR1 Origin: Human Host: HEK-293 Cells Synthetic Nanodisc
Catalog No. ABIN7491543
  • Target See all Angiotensin II Type-1 Receptor (AGTR1) Proteins
    Angiotensin II Type-1 Receptor (AGTR1) (Angiotensin II Receptor, Type 1 (AGTR1))
    Protein Type
    Synthetic Nanodisc
    Origin
    • 6
    • 1
    • 1
    Human
    Source
    • 2
    • 2
    • 2
    • 1
    • 1
    HEK-293 Cells
    Purpose
    Human AGTR1 full length protein-synthetic nanodisc
    Characteristics
    Unlike other membrane scaffold protein (MSP) Nanodisc on the market, our synthetic Nanodisc can be prepared directly from the cells. The polymers used during this process have a dual function. It dissolves the cell membranes, like the detergent, and uses cellular phospholipids to form Nanodisc around the membrane proteins. The target protein embedded Nanodiscs can then be purified.
    Top Product
    Discover our top product AGTR1 Protein
  • Comment

    Advantages of Synthetic Nanodiscs:

    • Highly purified membrane proteins
    • High solubility in aqueous solutions
    • High stability
    • Proteins are in a native membrane environment and remain biologically active
    • No detergent and can be used for cell-based assays
    • No MSP backbone proteins
    Limitations of Synthetic Nanodiscs:
    • Intolerant to acids and high concentrations of divalent metal ions

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Buffer
    Lyophilized from nanodisc solubilization buffer (20 mM Tris-HCl, 150 mM NaCl, pH 8.0). Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
    Storage
    -20 °C,-80 °C
    Storage Comment
    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
    Expiry Date
    12 months
  • Target
    Angiotensin II Type-1 Receptor (AGTR1) (Angiotensin II Receptor, Type 1 (AGTR1))
    Alternative Name
    AGTR1 (AGTR1 Products)
    Synonyms
    AG2S Protein, AGTR1A Protein, AGTR1B Protein, AT1 Protein, AT1AR Protein, AT1B Protein, AT1BR Protein, AT1R Protein, AT2R1 Protein, AT2R1A Protein, AT2R1B Protein, HAT1R Protein, 1810074K20Rik Protein, AI551199 Protein, AT1a Protein, Agtr-1a Protein, Agtr1 Protein, Angtr-1a Protein, AT1A Protein, XAT-1 Protein, agtr1-A Protein, agtr1.2 Protein, AT1-R Protein, at1 Protein, AGTR1 Protein, Agtr-1b Protein, Angtr-1b Protein, agtr1 Protein, agtr1-a Protein, agtr1-b Protein, xAT Protein, angiotensin II receptor type 1 Protein, angiotensin II receptor, type 1a Protein, angiotensin II receptor type 1 S homeolog Protein, uncharacterized AGTR1 Protein, angiotensin II receptor, type 1b Protein, angiotensin II receptor type 1 L homeolog Protein, AGTR1 Protein, Agtr1a Protein, agtr1.S Protein, Agtr1 Protein, Agtr1b Protein, agtr1.L Protein
    Background
    Angiotensin II is a potent vasopressor hormone and a primary regulator of aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. It acts through at least two types of receptors. This gene encodes the type 1 receptor which is thought to mediate the major cardiovascular effects of angiotensin II. This gene may play a role in the generation of reperfusion arrhythmias following restoration of blood flow to ischemic or infarcted myocardium. It was previously thought that a related gene, denoted as AGTR1B, existed, however, it is now believed that there is only one type 1 receptor gene in humans. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Aug 2020]
    Molecular Weight
    The human full length AGTR1 protein has a MW of 40.9 kDa
    UniProt
    P30556
    Pathways
    JAK-STAT Signaling, ACE Inhibitor Pathway, Regulation of Systemic Arterial Blood Pressure by Hormones, Feeding Behaviour
You are here: